Sex-specific associations between Neutrophil Gelatinase-Associated Lipocalin (NGAL) and cognitive domains in late-life depression

Psychoneuroendocrinology

Volumn 48, Issue , 2014, Pages 169-177

  Naude P J W ^a,b   den Boer, J A ^b   Comijs, H C ^c   Bosker, F J ^b   Zuidersma, M ^b   Groenewold, N A ^b   De Deyn, P P ^b,d   Luiten, P G M ^a,b   Eisel, U L M ^a,b   Oude Voshaar, R C ^b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Cognitive impairment; Executive functioning; HsCRP; IL 6; Inflammation; Lipocalin 2; NESDO; Verbal memory

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; ACUTE PHASE PROTEIN; IL6 PROTEIN, HUMAN; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN;

AGED; ARTICLE; ATTENTION; COGNITION; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; NETHERLANDS; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REY VERBAL LEARNING TEST; SEX DIFFERENCE; STROOP TEST; VERBAL MEMORY; WAIS DIGIT SPAN TEST; BLOOD; CLINICAL TRIAL; DEPRESSIVE DISORDER; INFLAMMATION; LEARNING; MEMORY; METABOLISM; MIDDLE AGED; ONSET AGE; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; VERY ELDERLY;

ACUTE-PHASE PROTEINS; AGE OF ONSET; AGED; AGED, 80 AND OVER; ATTENTION; C-REACTIVE PROTEIN; COGNITION; DEPRESSIVE DISORDER; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; LIPOCALINS; MALE; MEMORY; MIDDLE AGED; PROTO-ONCOGENE PROTEINS; SEX FACTORS; VERBAL LEARNING;

EID: 84904891909     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2014.06.016     Document Type: Article

References (56)

1. Alexopoulos G.S., Morimoto S.S. The inflammation hypothesis in geriatric depression. Int. J. Geriatr. Psychiatry 2011, 26:1109-1118.
2. American Psychiatric Association Diagnostic and statistical manual of mental disorders (4th ed., text rev.) 2000, Author, Washington, DC.
3. Baune B.T., Smith E., Reppermund S., Air T., Samaras K., Lux O., Brodaty H., Sachdev P., Trollor J.N. Inflammatory biomarkers predict depressive, but not anxiety symptoms during aging: the prospective Sydney Memory and Aging Study. Psychoneuroendocrinology 2012, 37:1521-1530.
4. Bi F., Huang C., Tong J., Qiu G., Huang B., Wu Q., Li F., Xu Z., Bowser R., Xia X.G., Zhou H. Reactive astrocytes secrete lcn2 to promote neuron death. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:4069-4074.
5. Bremmer M.A., Beekman A.T., Deeg D.J., Penninx B.W., Dik M.G., Hack C.E., Hoogendijk W.J. Inflammatory markers in late-life depression: results from a population-based study. J. Affect. Disord. 2008, 106:249-255.
6. Candore G., Balistreri C.R., Grimaldi M.P., Vasto S., Listì F., Chiappelli M., Licastro F., Lio D., Caruso C. Age-related inflammatory diseases. Ann. N.Y. Acad. Sci. 2006, 1089:472-486.
7. Canon M.E., Crimmins E.M. Sex differences in the association between muscle quality, inflammatory markers, and cognitive decline. J. Nutr. Health Aging 2011, 15:695-698.
8. Chaytor N., Schmitter-Edgecombe M. The ecological validity of neuropsychological tests: a review of the literature on everyday cognitive skills. Neuropsychology review 2003, 13:181-197.
9. Choi J., Lee H.-W., Suk K. Increased plasma levels of lipocalin 2 in mild cognitive impairment. J. Neurol. Sci. 2011, 305:28-33.
10. Comijs H.C., Van Marwijk H.W., Van Der Mast R.C., Naarding P., Oude Voshaar R.C., Beekman A.T., Boshuisen M., Dekker J., Kok R., De Waal M.W., Penninx B.W., Stek M.L., Smit J.H. The Netherlands study of depression in older persons (NESDO); a prospective cohort study. BMC Res. Notes 2011, 4:524.
11. Craig C.L., Marshall A.L., Sjostrom M., Bauman A.E., Booth M.L., Ainsworth B.E., Pratt M., Ekelund U., Yngve A., Sallis J.F., Oja P. International physical activity questionnaire: 12-country reliability and validity. Med. Sci. Sports Exerc. 2003, 35:1381-1395.
12. Di Carlo A., Baldereschi M., Amaducci L., Lepore V., Bracco L., Maggi S., Bonaiuto S., Perissinotto E., Scarlato G., Farchi G., Inzitari D. Incidence of dementia, Alzheimer's disease, and vascular dementia in Italy. The ILSA study. J. Am. Geriatr. Soc. 2002, 50:41-48.
13. Eikelenboom P., Veerhuis R., Scheper W., Rozemuller A.J., van Gool W.A., Hoozemans J.J. The significance of neuroinflammation in understanding Alzheimer's disease. J. Neural Transm. 2006, 113:1685-1695.
14. Elderkin-Thompson V., Irwin M.R., Hellemann G., Kumar A. Interleukin-6 and memory functions of encoding and recall in healthy and depressed elderly adults. Am. J. Geriatr. Psychiatry 2012, 20:753-763.
15. Elneihoum A.M., Falke P., Axelsson L., Lundberg E., Lindgarde F., Ohlsson K. Leukocyte activation detected by increased plasma levels of inflammatory mediators in patients with ischemic cerebrovascular diseases. Stroke 1996, 27:1734-1738.
16. Elneihoum A.M., Falke P., Hedblad B., Lindgarde F., Ohlsson K. Leukocyte activation in atherosclerosis: correlation with risk factors. Atherosclerosis 1997, 131:79-84.
17. Fox M., Berzuini C., Knapp L.A. Cumulative estrogen exposure, number of menstrual cycles, and Alzheimer's risk in a cohort of British women. Psychoneuroendocrinology 2013, 38:2973-2982.
18. Gao H., Liang M., Bergdahl A., Hamrén A., Lindholm M., Dahlman-Wright K., Nilsson B. Estrogen attenuates vascular expression of inflammation associated genes and adhesion of monocytes to endothelial cells. Inflamm. Res. 2006, 55:349-353.
19. Gao S., Hendrie H.C., Hall K.S., Hui S. The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis. Arch. Gen. Psychiatry 1998, 55:809-815.
20. Haroon E., Raison C.L., Miller A.H. Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology 2012, 37:137-162.
21. Jamshed N., Ozair F.F., Aggarwal P., Ekka M. Alzheimer disease in post-menopausal women: intervene in the critical window period. J. Mid-Life Health 2014, 5:38-40.
22. Kessler R.C., Birnbaum H., Bromet E., Hwang I., Sampson N., Shahly V. Age differences in major depression: results from the National Comorbidity Survey Replication (NCS-R). Psychol. Med. (Engl.) 2010, 225-237.
23. Klein M., Ponds R.W., Houx P.J., Jolles J. Effect of test duration on age-related differences in Stroop interference. J. Clin. Exp. Neuropsychol. 1997, 19:77-82.
24. Köhler S., Van Boxtel M.P.J., Van Os J., Thomas A.J., O'Brien J.T., Jolles J., Verhey F.R.J., Allardyce J. Depressive symptoms and cognitive decline in community-dwelling older adults. J. Am. Geriatr. Soc. 2010, 58:873-879.
25. Korten N.C., Penninx B.W., Kok R.M., Stek M.L., Oude Voshaar R.C., Deeg D.J., Comijs H.C. Heterogeneity of late-life depression: relationship with cognitive functioning. Int. Psychogeriatr. 2014, 26:953-963.
26. Kriegsman D.M., Penninx B.W., van Eijk J.T., Boeke A.J., Deeg D.J. Self-reports and general practitioner information on the presence of chronic diseases in community dwelling elderly. A study on the accuracy of patients' self-reports and on determinants of inaccuracy. J. Clin. Epidemiol. 1996, 49:1407-1417.
27. Lachner G., Engel R.R. Differentiation of dementia and depression by memory tests. A meta-analysis. J. Nerv. Ment. Dis. 1994, 182:34-39.
28. Launer L.J., Andersen K., Dewey M.E., Letenneur L., Ott A., Amaducci L.A., Brayne C., Copeland J.R.M., Dartigues J.-F., Kragh-Sorensen P., Lobo A., Martinez-Lage J.M., Stijnen T., Hofman A. Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia. Neurology 1999, 52:78-84.
29. Lehnardt S., Lachance C., Patrizi S., Lefebvre S., Follett P.L., Jensen F.E., Rosenberg P.A., Volpe J.J., Vartanian T. The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J. Neurosci. 2002, 22:2478-2486.
30. Leonard B.E. Inflammation, depression and dementia: are they connected?. Neurochem. Res. 2007, 32:1749-1756.
31. Marsland A.L., Petersen K.L., Sathanoori R., Muldoon M.F., Neumann S.A., Ryan C., Flory J.D., Manuck S.B. Interleukin-6 covaries inversely with cognitive performance among middle-aged community volunteers. Psychosom. Med. 2006, 68:895-903.
32. Mortimer J.A., Gosche K.M., Riley K.P., Markesbery W.R., Snowdon D.A. Delayed recall, hippocampal volume and Alzheimer neuropathology: findings from the Nun Study. Neurology 2004, 62:428-432.
33. Mucha M., Skrzypiec A.E., Schiavon E., Attwood B.K., Kucerova E., Pawlak R. Lipocalin-2 controls neuronal excitability and anxiety by regulating dendritic spine formation and maturation. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:18436-18441.
34. Naudé P.J., Eisel U.L., Comijs H.C., Groenewold N.A., De Deyn P.P., Bosker F.J., Luiten P.G., den Boer J.A., Oude Voshaar R.C. Neutrophil gelatinase-associated lipocalin: a novel inflammatory marker associated with late-life depression. J. Psychosom. Res. 2013, 75:444-450.
35. Naude P.J., Mommersteeg P.M., Zijlstra W.P., Gouweleeuw L., Kupper N., Eisel U.L., Kop W.J., Schoemaker R.G. Neutrophil gelatinase-associated lipocalin and depression in patients with chronic heart failure. Brain Behav. Immun. 2014, 38:59-65.
36. Naudé P.J.W., Nyakas C., Eiden L.E., Ait-Ali D., Heide R.v.d., Engelborghs S., Luiten P.G.M., De Deyn P.P., den Boer J.A., Eisel U.L.M. Lipocalin 2: novel component of proinflammatory signaling in Alzheimer's disease. FASEB J. 2012, 26:2811-2823.
37. O'Brien J.T., Erkinjuntti T., Reisberg B., Roman G., Sawada T., Pantoni L., Bowler J.V., Ballard C., DeCarli C., Gorelick P.B., Rockwood K., Burns A., Gauthier S., DeKosky S.T. Vascular cognitive impairment. Lancet Neurol. 2003, 2:89-98.
38. Prat A., Behrendt M., Marcinkiewicz E., Boridy S., Sairam R.M., Seidah N.G., Maysinger D. A novel mouse model of Alzheimer's disease with chronic estrogen deficiency leads to glial cell activation and hypertrophy. J. Aging Res. 2011, 2011:251517.
39. Rey A. L'examen clinique en psychologie 1964, Presses universitaires de France, Paris.
40. Ruitenberg A., Ott A., van Swieten J.C., Hofman A., Breteler M.M. Incidence of dementia: does gender make a difference?. Neurobiol. Aging 2001, 22:575-580.
41. Rushing N.C., Sachs-Ericsson N., Steffens D.C. Neuropsychological indicators of preclinical Alzheimer's disease among depressed older adults. Neuropsychol. Dev. Cogn. B: Aging Neuropsychol. Cogn. 2014, 21:99-128.
42. Sartori A.C., Vance D.E., Slater L.Z., Crowe M. The impact of inflammation on cognitive function in older adults: implications for healthcare practice and research. J. Neurosci. Nurs. 2012, 44:206-217.
43. Sheline Y.I., Sanghavi M., Mintun M.A., Gado M.H. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J. Neurosci. 1999, 19:5034-5043.
44. Sonnenberg C.M., Beekman A.T.F., Deeg D.J.H., van Tilburg W. Sex differences in late-life depression. Acta Psychiatr. Scand. 2000, 101:286-292.
45. Squire L.R., Stark C.E., Clark R.E. The medial temporal lobe. Annu. Rev. Neurosci. 2004, 27:279-306.
46. Stroop J.R. Studies of interference in serial verbal reactions. J. Exp. Psychol. 1935, 18:643-662.
47. Thomas A.J., Davis S., Morris C., Jackson E., Harrison R., O'Brien J.T. Increase in interleukin-1beta in late-life depression. Am. J. Psychiatry 2005, 162:175-177.
48. Thomas A.J., Gallagher P., Robinson L.J., Porter R.J., Young A.H., Ferrier I.N., O'Brien J.T. A comparison of neurocognitive impairment in younger and older adults with major depression. Psychol. Med. 2009, 39:725-733.
49. Thomas A.J., O'Brien J.T. Depression and cognition in older adults. Curr. Opin. Psychiatry 2008, 21:8-13.
50. Trollor J.N., Smith E., Agars E., Kuan S.A., Baune B.T., Campbell L., Samaras K., Crawford J., Lux O., Kochan N.A., Brodaty H., Sachdev P. The association between systemic inflammation and cognitive performance in the elderly: the Sydney Memory and Ageing Study. Age (Dordr.) 2012, 34:1295-1308.
51. van Nispen R.M., Knol D.L., Mokkink L.B., Comijs H.C., Deeg D.J., van Rens G.H. Vision-related quality of life core measure (VCM1) showed low-impact differential item functioning between groups with different administration modes. J. Clin. Epidemiol. 2010, 63:1232-1241.
52. Vegeto E., Benedusi V., Maggi A. Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases. Front. Neuroendocrinol. 2008, 29:507-519.
53. Wechsler D. The Measurement and Appraisal of Adult Intelligence 1958, Williams & Wilkins Co, Baltimore, MD, US. 4th ed.
54. World Health Organization (WHO) (WHO) Collaborating Centre for Drug Statistics Methodology 2011, http://www.whocc.no/atc_ddd_index/ (accessed January 2012).
55. Wise P.M. Neuroendocrine modulation of the "menopause": insights into the aging brain. Am. J. Physiol. 1999, 277:E965-E970.
56. Wittchen H.U., Robins L.N., Cottler L.B., Sartorius N., Burke J.D., Regier D. Cross-cultural feasibility, reliability and sources of variance of the Composite International Diagnostic Interview (CIDI). The Multicentre WHO/ADAMHA Field Trials. Br. J. Psychiatry 1991, 159:645-653. 658.